Cabozantinib exposure-response analysis for the phase 3 CheckMate 9ER trial of nivolumab plus cabozantinib versus sunitinib in first-line advanced renal cell carcinoma

卡博替尼暴露-反应分析：一项针对晚期肾细胞癌一线治疗中，卡博替尼联合纳武利尤单抗与舒尼替尼的3期CheckMate 9ER试验